You just read:

Lexent Bio Announces Use of its Liquid Biopsy Assay, Confera Dx, in a Peer-Reviewed Paper Published in the Journal Molecular Cancer Therapeutics

News provided by

Lexent Bio

May 14, 2020, 10:00 ET